RxDoctor Payments Data

Darshdeep Singh, DO

Orthopaedic Surgery · Dover, DENPI 1639334683

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (39.0%), education and speaking fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Arthrex at 47.1% of the total. Reporting peaked in 2019 at $3,858 and has fallen 53.7% since, to $1,787 in 2025.

$14,732in general payments, 2019–2025

Across 85 payments — averaging $173.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$7K
  • Supreme Orthopedic Systems, LLC$4K
  • Stryker$2K
  • Sonex Health, Inc.$1K
  • Smith+Nephew$217
  • Endo Pharmaceuticals Inc.$162
  • plus $610 from 11 others

What the payments were for

  • Speaking & faculty fees$3,00020%
  • Travel & lodging$5,74239%
  • Food & beverage$2,57317%
  • Education$3,41723%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,732 in reported general payments places this provider in the 70th percentile of 70 orthopaedic surgery providers in Delaware.

See all orthopaedic surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$324,860
Medicare patients
568
Services billed
3,387

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin103$288
Diclofenac Sodium30$287
Meloxicam12$218
Tramadol Hcl81$194
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$135
Methylprednisolone22$128
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen25$112
Clindamycin Hcl28$52

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Dover

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →